V003-2337 Screening compound: 2-{N-benzyl-1-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide

V003-2337 Screening compound: 2-{N-benzyl-1-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide
V003-2337 Screening compound: 2-{N-benzyl-1-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-2337
2-{N-benzyl-1-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-2337

Molecular Formula

C27H26N4O3 (C27 H26 N4 O3)

Compound Name

2-{N-benzyl-1-[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide

IUPAC name

2-{N-benzyl-1-[5-(25-dimethylphenyl)-12-oxazol-3-yl]formamido}-N-[(pyridin-3-yl)methyl]acetamide

SMILES

Cc1cc(-c2cc(C(N(CC(NCc3cnccc3)=O)Cc3ccccc3)=O)no2)c(C)cc1

InChI

InChI=1S/C27H26N4O3/c1-19-10-11-20(2)23(13-19)25-14-24(30-34-25)27(33)31(17-21-7-4-3-5-8-21)18-26(32)29-16-22-9-6-12-28-15-22/h3-15H,16-18H2,1-2H3,(H,29,32)

InChI Key

YWFAHBFDYGUWIH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19818483

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

454.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.870

Distribution Coefficient, logD

3.868

Water Solubility, LogSw

-3.60

Polar Surface Area

71.702

Acid Dissociation Constant (pKa)

14.04

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.50

V003-2337 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V003-2337 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-2337?
Check Price and Availability of V003-2337, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-2337 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-2337
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-2337
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-2337 available by request